1. Home
  2. WRBY vs EVO Comparison

WRBY vs EVO Comparison

Compare WRBY & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

N/A

Current Price

$27.49

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.65

Market Cap

568.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WRBY
EVO
Founded
2010
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
568.6M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
WRBY
EVO
Price
$27.49
$1.65
Analyst Decision
Buy
Buy
Analyst Count
14
3
Target Price
★ $30.46
$4.23
AVG Volume (30 Days)
★ 3.0M
143.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 105.88
N/A
EPS
★ 0.06
N/A
Revenue
★ $871,905,000.00
N/A
Revenue This Year
$11.38
N/A
Revenue Next Year
$17.05
$20.51
P/E Ratio
$468.00
★ N/A
Revenue Growth
★ 13.04
N/A
52 Week Low
$14.96
$1.50
52 Week High
$31.00
$4.27

Technical Indicators

Market Signals
Indicator
WRBY
EVO
Relative Strength Index (RSI) 59.80 46.64
Support Level $21.67 $1.50
Resistance Level $30.51 $1.97
Average True Range (ATR) 1.61 0.05
MACD 0.52 0.02
Stochastic Oscillator 91.35 76.00

Price Performance

Historical Comparison
WRBY
EVO

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: